Suppr超能文献

E-2078、吗啡和U-50,488E抗伤害感受作用中胺能参与的比较研究。

A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.

作者信息

Nakazawa T, Yamanishi Y, Kaneko T

机构信息

Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.

出版信息

J Pharmacol Exp Ther. 1991 May;257(2):748-53.

PMID:1674534
Abstract

E-2078 ([N-methyl-Tyr1, N-alpha-methyl-Arg7, D-Leu8]dynorphin A(1-8) ethylamide) is a systemically active dynorphin analog. We examined monoaminergic involvement in the antinociceptive action of E-2078 compared with morphine and U-50,488E (trans-3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)- benzene-acetamide monohydrochloride). The antinociceptive effect of these drugs was determined using the mouse tail-flick test after depletion of norepinephrine or 5-HT by pretreatment with various neurotoxins. Reserpine (i.p.) depleted both norepinephrine and 5-HT. Selective degeneration of noradrenergic nerves was induced by N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4, i.p.) or intrathecal (i.t.) 6-hydroxydopamine (6-OHDA), whereas 5-HT was depleted by p-chlorophenylalanine (PCPA, i.p.) or 5,7-dihydroxytryptamine (5,7-DHT, i.t.). The antinociceptive action of E-2078 administered s.c. was significantly attenuated in mice treated with reserpine, DSP-4, 6-OHDA, PCPA or 5,7-DHT compared with that in non-neurotoxin animals. Antinociception induced by intracerebroventricular (i.c.v.) and i.t. injection of E-2078 was reversed by reserpine, DSP-4 or PCPA. The antinociceptive action of morphine (s.c.) was attenuated by reserpine, DSP-4, 6-OHDA and PCPA, but not by 5,7-DHT. Antinociception produced by i.c.v. morphine was antagonized by reserpine, DSP-4 and PCPA. In contrast, morphine given i.t. was not affected by these neurotoxins. U-50,488E (s.c.)-induced antinociception was attenuated by reserpine, DSP-4, 6-OHDA, PCPA and 5,7-DHT. Intracerebroventricular U-50,488E was antagonized by reserpine, DSP-4 and PCPA, whereas i.t. U-50,488E was reversed only by reserpine and PCPA(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

E-2078([N-甲基-Tyr1,N-α-甲基-Arg7,D-亮氨酸8]强啡肽A(1-8)乙酰胺)是一种具有全身活性的强啡肽类似物。我们研究了与吗啡和U-50,488E(反式-3,4-二氯-N-甲基-N-(2-(1-吡咯烷基)-环己基)-苯乙酰胺盐酸盐)相比,单胺能系统在E-2078镇痛作用中的参与情况。在用各种神经毒素预处理使去甲肾上腺素或5-羟色胺耗竭后,通过小鼠甩尾试验测定这些药物的镇痛效果。利血平(腹腔注射)可使去甲肾上腺素和5-羟色胺均耗竭。N-(2-氯乙基)-N-乙基-2-溴苄胺(DSP-4,腹腔注射)或鞘内注射6-羟基多巴胺(6-OHDA)可诱导去甲肾上腺素能神经选择性变性,而对氯苯丙氨酸(PCPA,腹腔注射)或5,7-二羟色胺(5,7-DHT,鞘内注射)可使5-羟色胺耗竭。与未用神经毒素处理的动物相比,用利血平、DSP-4、6-OHDA、PCPA或5,7-DHT处理的小鼠皮下注射E-2078后的镇痛作用明显减弱。脑室注射和鞘内注射E-2078诱导的镇痛作用可被利血平、DSP-4或PCPA逆转。吗啡(皮下注射)的镇痛作用可被利血平、DSP-4、6-OHDA和PCPA减弱,但不受5,7-DHT影响。脑室注射吗啡产生的镇痛作用可被利血平、DSP-4和PCPA拮抗。相比之下,鞘内注射吗啡不受这些神经毒素影响。U-50,488E(皮下注射)诱导的镇痛作用可被利血平、DSP-4、6-OHDA、PCPA和5,7-DHT减弱。脑室注射U-50,488E可被利血平、DSP-4和PCPA拮抗,而鞘内注射U-50,488E仅被利血平和PCPA逆转(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验